The normal human prostate expresses inhibin and activin subunits. In prosta
te cancer, the inhibin alpha subunit gene is down regulated and this is ass
ociated with loss of heterozygosity (LOH) at the gene locus and methylation
of the promoter. These data support the hypothesis that the inhibin alpha
subunit is tumor suppressive in the prostate. The pluripotent effects of ac
tivins and the similarities to transforming growth factor beta (TFG beta) s
uggest a role for activins in progression to malignancy, whereby, the norma
l growth inhibitory action of activin A observed on benign cells is lost wi
th the acquisition of activin resistance in prostate cancer cells. The mech
anisms of rendering tumor cells resistant to activin A may include: alterat
ion in activin binding protein (follistatin) synthesis and/or dimerisation
with activin beta (C) to form novel activin dimers. The contribution of the
activin signalling cascade to malignancy requires further evaluation to id
entify the synergies and differences to other members of the TGF beta super
family, (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.